CaseBioscience Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
CaseBioscience® Selected for ARPA-H-Funded Initiative to Advance Ambient Preservation of Cell Therapies
CaseBioscience® has been selected to join a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS) program. The team’s Reversible Ambient Biostabilization (RAB) project aims to develop new approaches for preserving and transporting living cellular medicines at ambient temperatures, potentially reducing reliance on cold-chain logistics. CaseBioscience will contribute its expertise in clinical media formulation, biopreservation, and cellular metabolism to this collaborative research effort.
